Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Cost-effectiveness of TAVR in the non-surgical population.
Differentiation of Pathogenic Th17 Cells Is Negatively Regulated by Let-7 MicroRNAs in a Mouse Model of Multiple Sclerosis.
Early antiretroviral therapy in children perinatally infected with HIV: a unique opportunity to implement immunotherapeutic approaches to prolong viral remission.
Stability of large diffusion/perfusion mismatch in anterior circulation strokes for 4 or more hours.
See All 4 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cost-effectiveness of TAVR in the non-surgical population.
Reardon MJ, Reynolds MR. Cost-effectiveness of TAVR in the non-surgical population. J Med Econ. 2013; 16(4):575-9.
View in:
PubMed
subject areas
Aortic Valve Stenosis
Health Services
Heart Valve Prosthesis Implantation
Humans
authors with profiles
Matthew R Reynolds MD, MSc